clock menu more-arrow no yes

Filed under:

Prolexys Pharmaceuticals appoints new president/CEO

Salt Lake-based Prolexys Pharmaceuticals Inc. on Monday said David L. Clark has been appointed president and chief executive officer.

Clark recently served as vice president of corporate affairs at NPS Pharmaceuticals Inc. He also has worked for Agridine Technologies Inc.

His education background includes an MBA from the University of Utah.